Orexigen’s commitment to patients is reflected in all that we do: we are a company driven by the knowledge that our work is important and the desire to make a difference. Orexigen offers prospective employees exciting challenges, unique opportunities for career growth, and a fast-paced environment that emphasizes innovation and achievement.
Location: United States, California, San Diego
Employees: 51-200
Total raised: $225M
Investors 3
| Date | Name | Website |
| - | Domain Ass... | domainvc.c... |
| 07.08.2021 | New Enterp... | nea.com |
| - | Sofinnova ... | sofinnova.... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.03.2016 | - | $165M | - |
| 11.09.2015 | - | $60M | - |
Mentions in press and media 6
| Date | Title | Description |
| 12.03.2018 | With debt looming, browbeaten diet pill maker Orexigen goes bankrupt -- shares slide | Diet pill maker Orexigen Therapeutics is waving the white flag Monday morning after a years-long battle to bring its finances into the black. With crushing debt looming, the company is filing Chapter 11 bankruptcy in a... |
| 11.09.2015 | Orexigen Gets $60M In Private Placement | San Diego-based Orexigen Therapeutics, the publicly held biotech developer, said Thursday that it has raised $60M in a private placement. The funding came from The Baupost Group, LLC. Orexigenn Therapeutics said the new funding will go towa... |
| 12.09.2014 | The FDA Just Approved A New Diet Pill With Expected Sales Of $200 Million In 2016 — But There's A Catch | Marienbad Anti-Obesity Tablets were from an era before modern pharmaceuticals. The primary ingredients were herbal laxatives. Leeds Museums and Galleries / Flickr Redeem now The Food and Drug Administration has approved Contrave "as tr... |
| 28.12.2011 | Orexigen Raises $87M for Obesity Drug Trial | Orexigen Therapeutics Inc. said Dec. 22 it raised a net total of $86.9 million through a public offering of more than 5.6 million shares of stock. In its prospectus filed with the Securities and Exchange Commission, the La Jolla-based bioph... |
| 27.11.2006 | Roundup: Google’s offensive, and other post-Thanksgiving offers and deals & more | Here’s the latest tech stuff in Silicon Valley and elsewhere: Google keeps releasing new “gadgets” for its homepage — The latest are its NPR widget (see image), Wikipedia search and moon phases. You can place these gadgets on your google ho... |
| 22.11.2006 | Orexigen Therapeutics Raises $30M | San Diego-based Orexigen Therapeutics said today that it has completed a $30M Series C funding. The firm said that the funding will be used to advance its clinical programs. Funding came from new investors MPM BioEquities and Wasatch Adviso... |